OTCMKTS:ARSSF Assura (ARSSF) Stock Price, News & Analysis $0.68 0.00 (0.00%) As of 05/22/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort InterestBuy This Stock About Assura Stock (OTCMKTS:ARSSF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Assura alerts:Sign Up Key Stats Today's Range$0.68▼$0.6850-Day Range$0.68▼$0.6852-Week Range$0.43▼$0.72VolumeN/AAverage Volume9,153 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Assura PLC, trading as ARSSF on the OTC Markets, is a real estate investment trust specializing in primary healthcare facilities in the United Kingdom. The company acquires, develops and manages medical centres that are laid out for general practitioner (GP) practices, community health services and outpatient care. Assura structures long-term lease agreements with National Health Service (NHS) organisations and GP consortia, offering tailored financing and design solutions to meet evolving needs in primary care delivery. Since its establishment in 2003, Assura has built a diversified portfolio of primary care assets across England and Scotland. The company’s projects range from new-build developments to portfolio acquisitions and refurbishments of existing practices. By focusing exclusively on primary healthcare real estate, Assura aims to deliver stable, inflation-linked rental income while supporting health service providers in securing modern, fit-for-purpose premises. Headquartered in Altrincham, Cheshire, Assura is listed on the London Stock Exchange and abides by the regulatory framework governing UK real estate investment trusts. The company is managed by an experienced leadership team and overseen by an independent board of directors. Assura continues to pursue selective development and acquisition opportunities that align with its core strategy of partnering with NHS stakeholders and GP groups to enhance patient care infrastructure.AI Generated. May Contain Errors. Read More Receive ARSSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Assura and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARSSF Stock News HeadlinesLooking at the Narrative for Primary Health Properties After the Assura AcquisitionDecember 16, 2025 | uk.finance.yahoo.comWhy The Narrative Around Primary Health Properties Is Shifting After The Assura AcquisitionNovember 29, 2025 | finance.yahoo.comThis stock has 30 days of quiet leftA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When the SpaceX and xAI S-1 filing hits the SEC in June, analysts will comb through supplier disclosures and this company's name is expected to surface. Dylan Jovine has identified the ticker and laid out the full investment thesis. The stock is still quiet - but that window may be closing fast.May 26 at 1:00 AM | Behind the Markets (Ad)Primary Health Properties gets competition green light for Assura acquisitionOctober 29, 2025 | msn.comUK regulator clears Assura acquisition by Primary Health PropertiesOctober 29, 2025 | lse.co.ukPrimary Health Properties merger with Assura gets UK CMA clearanceOctober 29, 2025 | investing.comShore Capital Reiterates Assura (ARSSF) Hold RecommendationOctober 3, 2025 | msn.comPeel Hunt Limited Reiterates Assura (ARSSF) Buy RecommendationOctober 2, 2025 | msn.comSee More Headlines ARSSF Stock Analysis - Frequently Asked Questions How have ARSSF shares performed this year? Assura's stock was trading at $0.6780 on January 1st, 2026. Since then, ARSSF stock has decreased by 0.0% and is now trading at $0.6780. How do I buy shares of Assura? Shares of ARSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/26/2026Next Earnings (Estimated)5/26/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorReal Estate Industry REIT - Healthcare Facilities Sub-IndustryN/A Current SymbolOTCMKTS:ARSSF CIKN/A Webwww.assuraplc.com Phone44-1925-420660FaxN/AEmployees86Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (OTCMKTS:ARSSF) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersOpportunity Forming in a U.S. Supply-Chain Weak Spot?America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...i2i Marketing Group, LLC | SponsoredTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...Americas Gold Company | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredThe S-1 just dropped. 22 days left.The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...Behind the Markets | SponsoredHow institutional rebalancing quietly affects your retirement holdingsWhen a mega-IPO like SpaceX hits the market, the 60 days before the listing matter more than the day itself. P...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assura Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Assura With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
